NR3C1 and asthma: Individuals with type 2-high severe asthma demonstrate decreases in corticosteroid sensitivity, with studies implicating disruption in glucocorticoid receptor (GR) activity and persistently activated ILC2 populations (Chang et al., 2015; Liu et al., 2018).